This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignees: Fondazione Telethon, Ospedale San Raffaele S.r.l.. Active years: 2020.
Company Filing History:
1 out of 40 
1 out of 55 
Years Active: 2020
Title: Francesco Boccalatte: Innovator in Genetic Modification
Introduction
Francesco Boccalatte is a notable inventor based in Milan, Italy. He has made significant contributions to the field of genetic modification, particularly in the area of stem cell therapy. His innovative methods have the potential to advance clinical applications in regenerative medicine.
Latest Patents
Francesco Boccalatte holds a patent for "Methods for genetic modification of stem cells." This patent describes a method of preparing a therapeutic cell population for clinical use from a starting population of cells comprising haematopoietic stem cells. The method involves separating a population of cells that substantially do not express CD38 but do express CD34 from the starting population of cells. The separated cell population is then transduced with a vector to obtain the therapeutic cell population. He has 1 patent to his name.
Career Highlights
Throughout his career, Francesco has worked with esteemed organizations such as Ospedale San Raffaele S.r.l. and Fondazione Telethon. His work in these institutions has allowed him to contribute to groundbreaking research in the field of genetics and stem cell therapy.
Collaborations
Francesco has collaborated with prominent figures in the field, including Luigi Naldini and Bernhard Rudolf Gentner. These collaborations have further enriched his research and innovation efforts.
Conclusion
Francesco Boccalatte's work in genetic modification of stem cells represents a significant advancement in therapeutic applications. His contributions continue to influence the field of regenerative medicine and highlight the importance of innovation in healthcare.